{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:44:31Z","timestamp":1791902671883,"version":"4.3.4"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273780"],"award-info":[{"award-number":["82273780"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473773"],"award-info":[{"award-number":["82473773"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173681"],"award-info":[{"award-number":["82173681"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009110","name":"Natural Science Foundation of Xinjiang Uygur Autonomous Region","doi-asserted-by":"publisher","award":["2022D01D38"],"award-info":[{"award-number":["2022D01D38"]}],"id":[{"id":"10.13039\/100009110","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009110","name":"Natural Science Foundation of Xinjiang Uygur Autonomous Region","doi-asserted-by":"publisher","award":["2023D01D16"],"award-info":[{"award-number":["2023D01D16"]}],"id":[{"id":"10.13039\/100009110","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002857","name":"China Pharmaceutical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002857","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012172","name":"Double First Class University Plan","doi-asserted-by":"publisher","award":["CPU2022PZQ15"],"award-info":[{"award-number":["CPU2022PZQ15"]}],"id":[{"id":"10.13039\/501100012172","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["2632023TD04"],"award-info":[{"award-number":["2632023TD04"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ejmech.2025.118221","type":"journal-article","created":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T15:12:53Z","timestamp":1759072373000},"page":"118221","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Lipophilic integrated bioorthogonal self-catalyzed nitric oxide donor\u2013platinum(IV) prodrugs for enhanced antitumor efficacy against esophageal cancer"],"prefix":"10.1016","volume":"301","author":[{"given":"Ziyu","family":"Qian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xun","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zirui","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengshuang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiqin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ummatjon Gayrat Ugli","family":"Mustafaev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqi","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6409-8535","authenticated-orcid":false,"given":"Zhangjian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2725-9859","authenticated-orcid":false,"given":"Jianbing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.118221_bib1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/1759-7714.14745","article-title":"Epidemiology of esophageal cancer in 2020 and projections to 2030 and 2040","volume":"14","author":"Liu","year":"2023","journal-title":"Thorac. Cancer"},{"key":"10.1016\/j.ejmech.2025.118221_bib2","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ejmech.2025.118221_bib3","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1053\/j.gastro.2022.05.054","article-title":"The global landscape of esophageal squamous cell carcinoma and esophageal adenocarcinoma incidence and mortality in 2020 and projections to 2040: new estimates from GLOBOCAN 2020","volume":"163","author":"Morgan","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejmech.2025.118221_bib4","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s11894-023-00899-0","article-title":"Esophageal cancer: overview, risk factors, and reasons for the rise","volume":"25","author":"Lander","year":"2023","journal-title":"Curr. Gastroenterol. Rep."},{"key":"10.1016\/j.ejmech.2025.118221_bib5","first-page":"585","article-title":"Pristimerin induces Noxa-dependent apoptosis by activating the FoxO3a pathway in esophageal squamous cell carcinoma","volume":"23","author":"Feng","year":"2025","journal-title":"Chin. J. Nat. Med."},{"key":"10.1016\/j.ejmech.2025.118221_bib6","doi-asserted-by":"crossref","first-page":"55","DOI":"10.14740\/wjon1254","article-title":"Esophageal cancer: an updated surveillance epidemiology and end results database analysis","volume":"11","author":"Then","year":"2020","journal-title":"World J. Oncol."},{"key":"10.1016\/j.ejmech.2025.118221_bib7","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/cac2.12645","article-title":"Current status and perspectives of esophageal cancer: a comprehensive review","volume":"45","author":"Jiang","year":"2025","journal-title":"Cancer Commun."},{"key":"10.1016\/j.ejmech.2025.118221_bib8","doi-asserted-by":"crossref","first-page":"47330","DOI":"10.1021\/acsami.0c15419","article-title":"Leukocyte-mediated combined targeted chemo and gene therapy for esophageal cancer","volume":"12","author":"Jun","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.ejmech.2025.118221_bib9","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.3390\/cancers14061522","article-title":"Toward targeted therapies in oesophageal cancers: an overview","volume":"14","author":"Bregni","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ejmech.2025.118221_bib10","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/jjco\/hyz034","article-title":"Systemic treatment of advanced esophageal squamous cell carcinoma: chemotherapy, molecular-targeting therapy and immunotherapy","volume":"49","author":"Hirano","year":"2019","journal-title":"Jpn. J. Clin. Oncol."},{"key":"10.1016\/j.ejmech.2025.118221_bib11","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1080\/0284186X.2017.1307518","article-title":"Cocktail without hangover: in search for the optimal chemotherapy in the combined management of non-operable esophageal carcinomas","volume":"56","author":"So","year":"2017","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ejmech.2025.118221_bib12","doi-asserted-by":"crossref","first-page":"8113","DOI":"10.1039\/c0dt00292e","article-title":"The status of platinum anticancer drugs in the clinic and in clinical trials","volume":"39","author":"Wheate","year":"2010","journal-title":"Dalton Trans"},{"key":"10.1016\/j.ejmech.2025.118221_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114680","article-title":"The role of Platinum(IV)-based antitumor drugs and the anticancer immune response in medicinal inorganic chemistry. A systematic review from 2017 to 2022","volume":"243","author":"Su","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118221_bib14","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1158\/1078-0432.CCR-07-2176","article-title":"Current status and future prospects for satraplatin, an oral platinum analogue","volume":"14","author":"Choy","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejmech.2025.118221_bib15","doi-asserted-by":"crossref","first-page":"8790","DOI":"10.1021\/ja5038269","article-title":"Pt(IV) prodrugs designed to bind non-covalently to human serum albumin for drug delivery","volume":"136","author":"Zheng","year":"2014","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2025.118221_bib16","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.3390\/ijms22083817","article-title":"Pt(IV) prodrugs with NSAIDs as axial ligands","volume":"22","author":"Spector","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2025.118221_bib17","first-page":"4435","article-title":"Rational design of platinum chemotherapeutic drugs: hydrophobicity increases cytotoxicity","volume":"20","author":"Moeller","year":"2000","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ejmech.2025.118221_bib18","first-page":"445","article-title":"Overcoming cisplatin resistance: design of novel hydrophobic platinum compounds","volume":"20","author":"Tallen","year":"2000","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ejmech.2025.118221_bib19","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1002\/med.21360","article-title":"Recent advances in platinum (IV) complex-based delivery systems to improve platinum (II) anticancer therapy","volume":"35","author":"Han","year":"2015","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2025.118221_bib20","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/8276139","article-title":"Current developments in Pt(IV) prodrugs conjugated with bioactive ligands","author":"Li","year":"2018","journal-title":"Bioinorg Chem Appl"},{"key":"10.1016\/j.ejmech.2025.118221_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbpa.2023.102303","article-title":"Beyond mere DNA damage: recent progress in platinum(IV) anticancer complexes containing multi-functional axial ligands","volume":"74","author":"Deng","year":"2023","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.ejmech.2025.118221_bib22","doi-asserted-by":"crossref","first-page":"148","DOI":"10.2478\/raon-2019-0018","article-title":"Cisplatin and beyond: molecular mechanisms of action and drug resistance development in cancer chemotherapy","volume":"53","author":"Makovec","year":"2019","journal-title":"Radiol. Oncol."},{"key":"10.1016\/j.ejmech.2025.118221_bib23","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1053\/sonc.2002.35525","article-title":"Clinical aspects and molecular basis of oxaliplatin neurotoxicity: current management and development of preventive measures","volume":"29","author":"Gamelin","year":"2002","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.ejmech.2025.118221_bib24","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jinorgbio.2018.11.008","article-title":"Multi-action Pt(IV) anticancer agents; do we understand how they work?","volume":"191","author":"Gibson","year":"2019","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.ejmech.2025.118221_bib25","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1021\/jm070280u","article-title":"Basis for design and development of platinum(IV) anticancer complexes","volume":"50","author":"Hall","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118221_bib26","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s00280-016-2976-z","article-title":"Platinum-based drugs: past, present and future","volume":"77","author":"Dilruba","year":"2016","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118221_bib27","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1016\/j.cell.2022.06.010","article-title":"Nitric oxide signaling in health and disease","volume":"185","author":"Lundberg","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2025.118221_bib28","first-page":"619","article-title":"Inonotus obliquus (Chaga) against HFD\/STZ-induced glucolipid metabolism disorders and abnormal renal functions by regulating NOS-cGMP-PDE5 signaling pathway","volume":"22","author":"Feng","year":"2024","journal-title":"Chin. J. Nat. Med."},{"key":"10.1016\/j.ejmech.2025.118221_bib29","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.redox.2015.08.013","article-title":"Nitric oxide-mediated sensitization of resistant tumor cells to apoptosis by chemo-immunotherapeutics","volume":"6","author":"Bonavida","year":"2015","journal-title":"Redox Biol."},{"key":"10.1016\/j.ejmech.2025.118221_bib30","doi-asserted-by":"crossref","first-page":"7617","DOI":"10.1021\/acs.jmedchem.6b01672","article-title":"Nitric oxide donor-based cancer therapy: advances and prospects","volume":"60","author":"Huang","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118221_bib31","first-page":"1","article-title":"Overcoming KRAS-mutant lung cancer","volume":"42","author":"Luo","year":"2022","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1016\/j.ejmech.2025.118221_bib32","doi-asserted-by":"crossref","first-page":"5902","DOI":"10.1021\/acs.jmedchem.1c02194","article-title":"Protein S-Nitrosation: biochemistry, identification, molecular mechanisms, and therapeutic applications","volume":"65","author":"Ye","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118221_bib33","doi-asserted-by":"crossref","first-page":"7261","DOI":"10.1021\/acs.jmedchem.1c00599","article-title":"Discovery of RRx-001, a myc and CD47 downregulating small molecule with tumor targeted cytotoxicity and healthy tissue cytoprotective properties in clinical development","volume":"64","author":"Oronsky","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118221_bib34","first-page":"916","article-title":"Discovery and bioassay of disubstituted \u03b2-elemene-NO donor conjugates: synergistic enhancement in the treatment of leukemia","volume":"21","author":"Zhu","year":"2023","journal-title":"Chin. J. Nat. Med."},{"key":"10.1016\/j.ejmech.2025.118221_bib35","doi-asserted-by":"crossref","first-page":"14276","DOI":"10.1002\/chem.201201605","article-title":"Nitric oxide donor-based platinum complexes as potential anticancer agents","volume":"18","author":"Zhao","year":"2012","journal-title":"Chemistry"},{"key":"10.1016\/j.ejmech.2025.118221_bib36","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1097\/00005537-200111000-00004","article-title":"Nitric oxide improves cisplatin cytotoxicity in head and neck squamous cell carcinoma","volume":"111","author":"Azizzadeh","year":"2001","journal-title":"Laryngoscope"},{"key":"10.1016\/j.ejmech.2025.118221_bib37","doi-asserted-by":"crossref","first-page":"5148","DOI":"10.1021\/acscatal.1c00438","article-title":"Tools and methods for investigating synthetic metal-catalyzed reactions in living cells","volume":"11","author":"Nguyen","year":"2021","journal-title":"ACS Catal."},{"key":"10.1016\/j.ejmech.2025.118221_bib38","doi-asserted-by":"crossref","first-page":"13899","DOI":"10.1021\/acs.jmedchem.0c01435","article-title":"General strategy for integrated bioorthogonal prodrugs: Pt(II)-Triggered depropargylation enables controllable drug activation in vivo","volume":"63","author":"Sun","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118221_bib39","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1021\/acs.jmedchem.3c01693","article-title":"Development of integrated bioorthogonal self-catalyzed NO Donor\/Platinum(IV) prodrugs for synergistical intervention against triple-negative breast cancer","volume":"67","author":"Zhang","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118221_bib40","doi-asserted-by":"crossref","first-page":"5227","DOI":"10.1021\/jm0708275","article-title":"Calculation of lipophilicity of a large, diverse dataset of anticancer platinum complexes and the relation to cellular uptake","volume":"50","author":"Oldfield","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118221_bib41","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jinorgbio.2012.06.013","article-title":"What do we know about the reduction of Pt(IV) pro-drugs?","volume":"117","author":"Wexselblatt","year":"2012","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.ejmech.2025.118221_bib42","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.ejmech.2018.08.034","article-title":"Redox-responsive nano-carriers as tumor-targeted drug delivery systems","volume":"157","author":"Raza","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118221_bib43","doi-asserted-by":"crossref","first-page":"7427","DOI":"10.1039\/C4CC00419A","article-title":"The ligation of aspirin to cisplatin demonstrates significant synergistic effects on tumor cells","volume":"50","author":"Cheng","year":"2014","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejmech.2025.118221_bib44","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1021\/acs.bioconjchem.7b00117","article-title":"Anticancer Platinum(IV) prodrugs containing monoaminophosphonate ester as a targeting group inhibit matrix metalloproteinases and reverse multidrug resistance","volume":"28","author":"Huang","year":"2017","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.ejmech.2025.118221_bib45","doi-asserted-by":"crossref","first-page":"4686","DOI":"10.1016\/j.bmc.2017.07.011","article-title":"Platinum(IV) complexes conjugated with phenstatin analogue as inhibitors of microtubule polymerization and reverser of multidrug resistance","volume":"25","author":"Huang","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118221_bib46","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1039\/B922209J","article-title":"Exploring the cellular accumulation of metal complexes","volume":"39","author":"Puckett","year":"2010","journal-title":"Dalton Trans"},{"key":"10.1016\/j.ejmech.2025.118221_bib47","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jinorgbio.2010.09.006","article-title":"Tuning of lipophilicity and cytotoxic potency by structural variation of anticancer platinum(IV) complexes","volume":"105","author":"Reithofer","year":"2011","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.ejmech.2025.118221_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jinorgbio.2015.05.012","article-title":"Cellular trafficking, accumulation and DNA platination of a series of cisplatin-based dicarboxylato Pt(IV) prodrugs","volume":"150","author":"Ravera","year":"2015","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.ejmech.2025.118221_bib49","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jinorgbio.2016.03.005","article-title":"The role of the equatorial ligands for the redox behavior, mode of cellular accumulation and cytotoxicity of platinum(IV) prodrugs","volume":"160","author":"G\u00f6schl","year":"2016","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.ejmech.2025.118221_bib50","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jinorgbio.2003.08.014","article-title":"Uptake of antitumor platinum(II)-complexes by cancer cells, assayed by inductively coupled plasma mass spectrometry (ICP-MS)","volume":"98","author":"Ghezzi","year":"2004","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.ejmech.2025.118221_bib51","first-page":"185","article-title":"Maackiain inhibits proliferation and promotes apoptosis of nasopharyngeal carcinoma cells by inhibiting the MAPK\/Ras signaling pathway","volume":"21","author":"Jiang","year":"2023","journal-title":"Chin. J. Nat. Med."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425009869?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425009869?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T11:33:22Z","timestamp":1773142402000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425009869"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":51,"alternative-id":["S0223523425009869"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118221","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipophilic integrated bioorthogonal self-catalyzed nitric oxide donor\u2013platinum(IV) prodrugs for enhanced antitumor efficacy against esophageal cancer","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118221","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118221"}}